SGLT2-inhibitors and euglycemic diabetic ketoacidosis in COVID-19 pandemic era: a case report

被引：2
作者：
Secinaro, Enzo [1 ,2 ]
Ciavarella, Simone [1 ,2 ]
Rizzo, Giulia [1 ,2 ]
Porreca, Ettore [1 ,2 ]
Vitacolonna, Ester [2 ,3 ,4 ]
机构：
[1] G DAnnunzio Univ Chieti Pescara, Sch Med & Hlth Sci, Dept Innovat Technol Med & Dent, Chieti, Italy
[2] SS Annunziata Hosp Chieti, Div Internal Med, Dept Internal Med, Chieti, Italy
[3] SS Annunziata Hosp Chieti, Diabet Nutr & Metab Dis Unit, Chieti, Italy
[4] GD Annunzio Univ Chieti Pescara, Dept Med & Ageing Sci, Chieti, Italy
来源：
ACTA DIABETOLOGICA | 2022年 / 59卷 / 10期
关键词：
SGLT2-inhibitors; Euglycemic diabetic ketoacidosis; COVID-19; Low-carbohydrate intake; LADA;
D O I：
10.1007/s00592-022-01909-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1391 / 1394
页数：4
相关论文
共 5 条
  • [1] Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
    Buzzetti, Raffaella
    Tuomi, Tiinamaija
    Mauricio, Didac
    Pietropaolo, Massimo
    Zhou, Zhiguang
    Pozzilli, Paolo
    Leslie, Richard David
    [J]. DIABETES, 2020, 69 (10) : 2037 - 2047
  • [2] Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Colacci, Michael
    Fralick, John
    Odutayo, Ayodele
    Fralick, Michael
    [J]. CANADIAN JOURNAL OF DIABETES, 2022, 46 (01) : 10 - +
  • [3] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
    Ponikowski, Piotr
    Voors, Adriaan A.
    Anker, Stefan D.
    Bueno, Hector
    Cleland, John G. F.
    Coats, Andrew J. S.
    Falk, Volkmar
    Ramon Gonzalez-Juanatey, Jose
    Harjola, Veli-Pekka
    Jankowska, Ewa A.
    Jessup, Mariell
    Linde, Cecilia
    Nihoyannopoulos, Petros
    Parissis, John T.
    Pieske, Burkert
    Riley, Jillian P.
    Rosano, Giuseppe M. C.
    Ruilope, Luis M.
    Ruschitzka, Frank
    Rutten, Frans H.
    van der Meer, Peter
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2129 - U130
  • [4] Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
    Rosenstock, Julio
    Ferrannini, Ele
    [J]. DIABETES CARE, 2015, 38 (09) : 1638 - 1642
  • [5] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
    Rosenstein, Robert
    Hough, Augustus
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) : 1093 - 1094
1